Inhibition of CDK5 in the lung cancer cells suppresses cell proliferation and migration and reduces tumor growth and invasion.440 These effects could be due to the ability of CDK5 to affect cytoskeletal remodeling, leading to loss of cell polarity and impacts on proliferation, migration and vasculogenic mimicry formation.441. Here, CDK5 is linked to lung carcinoma.